Advertisement

FDA Approves First Treatment for Geographic Atrophy

0

Pegcetacoplan approved as an injection with dosing every 25 to 60 days

FDA Widens Warning for Contaminated Eye Products

0

At least 16 patients had been hospitalized earlier for an outbreak of the 'rare, extensively drug-resistant' Pseudomonas aeruginosa bacteria

Transcendental Meditation Helps to Alleviate Burnout in Academic Physicians

0

Benefits seen for total burnout, emotional exhaustion, and depression at four months

Disparities Seen in Surgical Resident Representation, Attrition

0

Risk for attrition significantly higher for female and underrepresented-in-medicine residents, particularly Black residents

Prior Paid Medical Malpractice Claims Predict Future Claims Risk

0

Findings independent of whether a physician is practicing in a high- or low-risk specialty

Drugs With Low Clinical Benefit Show Higher Direct-to-Consumer Spending

0

Majority of the top-selling prescription drugs sold in 2020 were rated as offering low added benefit

10 Percent of New Drugs Approved Without Meeting Primary Efficacy End Points

0

Findings seen for 21 drug approvals between 2018 and 2021, with only one-third needing postmarketing studies

Data Show Big Drop in Number of Americans in Medical Debt

0

Number of Americans with medical debt on their credit reports fell by 8.2 million from 2020 to 2022

0.05 Percent Atropine Eye Drops Result in Lower Incidence of Myopia

0

Incidence of myopia and percentage of patients with fast myopic shift lower with 0.05 percent atropine versus placebo among children aged 4 to 9 years without myopia at baseline

Practicing Physicians Saw Excess Mortality During COVID-19 Pandemic

0

However, physicians had substantially lower excess mortality than the general U.S. population